Keratoconus - Biomarkers and Questionnaire

NCT ID: NCT02887326

Last Updated: 2018-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

287 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The biomarker study adds to our previous study on biomarkers in tear fluid. In this study the investigators examine wether the biomarker levels are in correlation with the disease level and duration of disease.

The questionnaire study focuses on the patients perspective. With a validated questionnaire fore keratoconus patient it examine the patients self.-evaluated visual challenges and quality of life

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Keratoconus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

age 15-25 years

Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples

No interventions assigned to this group

age 25-35 years

Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples

No interventions assigned to this group

age 35-45 year

Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples

No interventions assigned to this group

> age 45 year

Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Keratoconus residint in the Central Denmark Region

Exclusion Criteria

* Other eye diseases
* Ocular traumas.
Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AUH-3828

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Customized Contact Lenses
NCT05134909 UNKNOWN NA
Prevelance of Keratoconus
NCT04092426 UNKNOWN